Total Funding
83
39
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
331932
TransCardiac Therapeutics develops technologies to facilitate access to the human heart.
Ahmed Zaki: CFO- Omar Lattouf: Founder
About the Company
Based in Atlanta, Georgia, TransCardiac Therapeutics was founded in 2003 by Omar Lattouf MD PhD of Emory University in order to develop and pursue commercialization of technologies he invented to enable and enhance minimally invasive cardiac therapies.TransCardiac Therapeutics is developing technologies to facilitate access to specific sites on the
inside and outside of the human heart without the need for a large surgical incision in the patient’s chest. These technologies can be used without stopping the patient’s heart and without connecting the patient to a heart lung machine.
Women Founded
